Abstract
We examined if TRPA1, like TRPV1, contributes to pancreatic nociceptor excitation following proteinase-activated receptor-2 (PAR2) stimulation and to pancreatitis-related pain in mice. A PAR2-activating peptide, infused into the pancreatic duct, caused spinal Fos expression, which was prevented by AP18, a TRPA1 inhibitor. Repeated administration of cerulein caused referred hyperalgesia accompanying pancreatitis, which was reversed by SB366791, a TRPV1 inhibitor, but not AP18. AP18, administered in combination with a subeffective dose of SB366791, significantly suppressed the referred hyperalgesia. Our findings suggest that TRPA1, like TRPV1, mediates PAR2-triggered pancreatic nociception and that TRPA1 in collaboration with TRPV1 latently contributes to pancreatitis-related pain. © The Japanese Pharmacological Society.
Author supplied keywords
Cite
CITATION STYLE
Terada, Y., Fujimura, M., Nishimura, S., Tsubota, M., Sekiguchi, F., Nishikawa, H., & Kawabata, A. (2013). Contribution of TRPA1 as a downstream signal of proteinase-activated receptor-2 to pancreatic pain. Journal of Pharmacological Sciences, 123(3), 284–287. https://doi.org/10.1254/jphs.13128SC
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.